Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
about
Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticlesDevelopment and evaluation of sunscreen creams containing morin-encapsulated nanoparticles for enhanced UV radiation protection and antioxidant activity.A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies.Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol.Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.Preparation and In Vivo Pharmacokinetics of the Tongshu Suppository.Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCImprovement of dissolution and hypoglycemic efficacy of glimepiride by different carriers.Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.Formulation and physicochemical characterization of chitosan/acyclovir co-crystals.Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity.Gastroretentive pulsatile release tablets of lercanidipine HCl: development, statistical optimization, and in vitro and in vivo evaluation.Preparation and evaluation of chitosan–itraconazole co-precipitated nanosuspension for ocular deliveryPreparation and characterization of chitosan microparticles for oral sustained delivery of gliclazide: in vitro/in vivo evaluationDesign and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluationDesign and development of gliclazide-loaded chitosan for oral sustained drug delivery:In vitro/in vivoevaluation
P2860
Q33834542-CF574CA3-7499-4E55-9C0F-476892900E35Q34280209-CF745EDB-FD65-491F-9ABF-D0DAA44FFA0EQ36176798-15686732-0557-4AE7-ACA6-F42ED1B486C2Q38661401-03A58F9F-1217-444F-AC71-B614F3D3C35CQ39478705-B4B8AE48-C65D-4513-A795-3D291A067338Q39922931-74FE92D7-2B09-4F7E-9B4F-4F770672D3BBQ40970740-1CF758DA-4E13-4870-A7D0-DCA3DC42523BQ41545455-606E4343-3861-4C34-A348-307E74824374Q41948835-C6C311E3-63A9-4186-B161-9145FE81E512Q41954156-CF7209B9-E7A3-4A94-A204-E2A81E9DCA8FQ41989240-6311D2FC-D94B-4DDA-BE00-3A4950089CFAQ42442565-6C2C5F27-AEA9-4D8E-8DED-310976381FF7Q46163854-E4716B84-AF11-4C4A-960B-50AB037E6C67Q54956078-FF9ECA69-B34C-4142-AE46-7AC684F17713Q55450659-DE8D1B21-8F19-4290-84AE-A4E910355D0AQ56027212-1FA0FC82-BC27-4BD2-8A58-21C7365889C2Q57342456-3B11A550-6911-4E68-92BC-54DD8E62576CQ57348918-4DC40DC4-FFDB-4CD9-9F26-6A493C558D0DQ57349903-FF29EB8C-A02B-4B6C-A7FE-77FEA1187619
P2860
Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Enhancement of dissolution rat ...... based solvent change approach.
@en
Enhancement of dissolution rat ...... based solvent change approach.
@nl
type
label
Enhancement of dissolution rat ...... based solvent change approach.
@en
Enhancement of dissolution rat ...... based solvent change approach.
@nl
prefLabel
Enhancement of dissolution rat ...... based solvent change approach.
@en
Enhancement of dissolution rat ...... based solvent change approach.
@nl
P2093
P1476
Enhancement of dissolution rat ...... based solvent change approach.
@en
P2093
Achutha Nayak Usha
Krishnan Manoj
Parambil Anju
P304
P356
10.1016/J.IJPHARM.2007.09.006
P407
P577
2007-09-12T00:00:00Z